Kunming Pharma will Raise $110 Million to Boost Capacity

Kunming Pharmaceutical will raise 700 million RMB ($110 million) by issuing a secondary offering of 68 million shares. The company will use the proceeds to increase its capacity, particularly small-volume injection products and a modern TCM facility. It will also increase its internationalization efforts. Thirty institutional buyers have already subscribed to the offering. More details.... Stock Symbol: (SHA: 600422)     Share this with colleagues: